TCL Archive Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.” July 18, 2008
TCL Archive Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says February 20, 1998
TCL Archive Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy May 30, 2014
